Evicenter
MarkdownMedical informationP&T meetings
Lanifibranor (IVA337)

Metabolic dysfunction-associated steatohepatitis with F2 to F3 fibrosis

Manufacturer
Inventiva
Last updated
220 sources

Product information and disease descriptionPlace of product in therapyDisease description

Natural history, survival, and mortality

17 evidence topics · 17 sources

Progression to cirrhosis and all-cause mortality in non-cirrhotic MASH F2 and F3: US TARGET-NASH cohort, 2,378 participants

“Among the 2378 patients included in this analysis, 48% had MASH cirrhosis.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote

“Among the 1425 patients with non-cirrhotic MASH, there were 982 patients in the F0–F1 cohort, 281 patients in the F2 cohort, and 162 patients in the F3 cohort (Supplemental Fig. 2).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote

“Incidence rates of cirrhosis increased from 0.34/100PM in the F0–F1 cohort to 1.24/100PM in the F2 cohort and 6.62/100PM in the F3 cohort (Table 5). Unadjusted risk of progressing to cirrhosis was highest among those with F3 (HR, 95% CI; 18.66, 10.97–31.73) and 3.74 times higher with F2 (HR, 95% CI; 3.74, 2.00–6.98) versus F0–F1 (Fig. 3).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote

“All-cause mortality was associated with disease severity and incidence rates increased from 0.14/100PM in the F0–F1 cohort to 0.3/100PM in the F2 cohort, 0.42/100PM in the F3 cohort, 2.02/100PM in the compensated cirrhosis cohort and 4.62/100PM in the decompensated cirrhosis cohort (Table 5).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote

“This analysis was supported by Novo Nordisk Inc., Plainsboro, NJ.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote

US deaths from chronic liver disease and cirrhosis of all causes, 2024
MeasureValue
Number of deaths“52,274”
Deaths per 100,000 population“15.4”
Cause of death rank“9”